XLV Holdings: Equity List and Weights
Health Care Select Sector SPDR ETF
61 positive-weight equity holdings in this dataset · State Street (SPDR) · holdings as of 2026-10-08
This list covers equity positions represented in the dataset. Cash, derivatives, options, structured notes, and other non-equity assets are excluded, so the listed weights may not sum to 100% and are not a complete inventory of every fund asset.
What does XLV actually hold?
XLV (Health Care Select Sector SPDR ETF) has 61 positive-weight equity holdings represented in this dataset as of 2026-10-08. The source type is issuer daily holdings file from State Street (SPDR). The three largest positions are Eli Lilly + Co at 15.31%, Johnson + Johnson at 10.11%, and Abbvie Inc at 7.87% of the fund. The ten largest equity holdings together account for 60.4 percentage points of reported fund exposure. The largest sector exposure is Health Care at 99.7%. Among the 80 funds tracked here, XLV overlaps most with SCHB, sharing 7.4% of weight by the smaller-of-the-two method. Anyone holding XLV next to another broad fund can own the same companies twice without seeing it, because a fund-level allocation says nothing about the stocks underneath. Every weight shown on this page is read from the source dataset dated 2026-10-08, not estimated or modelled by OverlapCheck.
Holdings source and freshness
- Issuer
- State Street (SPDR)
- Source type
- issuer daily holdings file (
issuer_daily) - Holdings as of
- Source status
ok- Source checked
- Filing date
- Not supplied in the dataset
- SEC accession
- Not supplied in the dataset
- Source link
- Not supplied in the dataset
All 61 represented equity positions are available on this page. The largest 61 are included in the initial HTML; search or load more to browse the rest in manageable chunks. The ten largest account for 60.4 percentage points of reported exposure in the issuer daily holdings file dated 2026-10-08.
XLV equity holdings
Showing the largest 61 of 61 positive-weight equity holdings in the initial HTML, ordered from highest to lowest reported weight. Search or load additional chunks to browse the complete list without leaving this page.
Showing 61 of 61 holdings.
| # | Company | Ticker | % of fund |
|---|---|---|---|
| 1 | Eli Lilly + Co | LLY | 15.31% |
| 2 | Johnson + Johnson | JNJ | 10.11% |
| 3 | Abbvie Inc | ABBV | 7.87% |
| 4 | Merck + Co. Inc. | MRK | 5.75% |
| 5 | Unitedhealth Group Inc | UNH | 5.45% |
| 6 | Thermo Fisher Scientific Inc | TMO | 3.94% |
| 7 | Amgen Inc | AMGN | 3.60% |
| 8 | Gilead Sciences Inc | GILD | 2.98% |
| 9 | Abbott Laboratories | ABT | 2.79% |
| 10 | Pfizer Inc | PFE | 2.59% |
| 11 | Intuitive Surgical Inc | ISRG | 2.40% |
| 12 | Danaher Corp | DHR | 2.23% |
| 13 | Vertex Pharmaceuticals Inc | VRTX | 2.09% |
| 14 | Bristol Myers Squibb Co | BMY | 1.99% |
| 15 | Medtronic Plc | MDT | 1.84% |
| 16 | Cvs Health Corp | CVS | 1.84% |
| 17 | Mckesson Corp | MCK | 1.77% |
| 18 | Stryker Corp | SYK | 1.58% |
| 19 | Elevance Health Inc | ELV | 1.42% |
| 20 | The Cigna Group | CI | 1.21% |
| 21 | Moderna Inc | MRNA | 1.20% |
| 22 | Regeneron Pharmaceuticals | REGN | 1.19% |
| 23 | Hca Healthcare Inc | HCA | 1.07% |
| 24 | Cencora Inc | COR | 1.00% |
| 25 | Boston Scientific Corp | BSX | 1.00% |
| 26 | Cardinal Health Inc | CAH | 0.91% |
| 27 | Becton Dickinson And Co | BDX | 0.81% |
| 28 | Edwards Lifesciences Corp | EW | 0.79% |
| 29 | Agilent Technologies Inc | A | 0.78% |
| 30 | Humana Inc | HUM | 0.76% |
| 31 | Iqvia Holdings Inc | IQV | 0.70% |
| 32 | Veeva Systems Inc Class A | VEEV | 0.70% |
| 33 | Waters Corp | WAT | 0.69% |
| 34 | Idexx Laboratories Inc | IDXX | 0.66% |
| 35 | Illumina Inc | ILMN | 0.65% |
| 36 | Resmed Inc | RMD | 0.54% |
| 37 | Biogen Inc | BIIB | 0.53% |
| 38 | Centene Corp | CNC | 0.52% |
| 39 | Dexcom Inc | DXCM | 0.52% |
| 40 | Mettler Toledo International | MTD | 0.50% |
| 41 | Zoetis Inc | ZTS | 0.49% |
| 42 | Ge Healthcare Technology | GEHC | 0.47% |
| 43 | West Pharmaceutical Services | WST | 0.42% |
| 44 | Labcorp Holdings Inc | LH | 0.42% |
| 45 | Quest Diagnostics Inc | DGX | 0.42% |
| 46 | Steris Plc | STE | 0.34% |
| 47 | Viatris Inc | VTRS | 0.33% |
| 48 | Incyte Corp | INCY | 0.31% |
| 49 | Revvity Inc | RVTY | 0.28% |
| 50 | Zimmer Biomet Holdings Inc | ZBH | 0.28% |
| 51 | Charles River Laboratories | CRL | 0.23% |
| 52 | Solventum Corp | SOLV | 0.20% |
| 53 | Baxter International Inc | BAX | 0.20% |
| 54 | Bio Techne Corp | TECH | 0.19% |
| 55 | Cooper Cos Inc/The | COO | 0.17% |
| 56 | Insulet Corp | PODD | 0.15% |
| 57 | Align Technology Inc | ALGN | 0.15% |
| 58 | Universal Health Services B | UHS | 0.15% |
| 59 | Henry Schein Inc | HSIC | 0.13% |
| 60 | Davita Inc | DVA | 0.10% |
| 61 | Xav Health Care Dec26 | IXCZ6 | <0.01% |
Hold XLV alongside other funds? The same stock can sit in several of them at once — see your true combined exposure →
Sector breakdown
Sectors assigned via S&P 500 sector-ETF membership; small-cap and international holdings appear as Unclassified. See methodology.
Overlaps most with
Lowest holdings overlap
These are the lowest holdings-overlap scores among the funds tracked here, not fund recommendations. Holdings overlap does not measure correlation, volatility, geographic or factor exposure, fees, or suitability.
XLV options dashboard
XLV has a liquid options market. Our sister site Quant Data computes max pain, put/call ratio, and open-interest walls for XLV nightly from end-of-day open interest.
→ See what XLV plus your other funds really hold, combined
Combining XLV with other funds is the stock-intersection view — the piece people miss most from the retired Morningstar Instant X-Ray. Here's our Morningstar Instant X-Ray alternative.